RWM
PBYI icon

Raffa Wealth Management’s Puma Biotechnology PBYI Stock Holding History

Raffa Wealth Management’s Portfolio PBYI Stock Details PBYI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-5
Closed -$1.18K – 830
2015
Q1 		$1.18K Hold
5
– – ﹤0.01% 349
2014
Q4 		$946 Hold
5
– – ﹤0.01% 371
2014
Q3 		$1.19K Sell
5
-3
-38% -$616 ﹤0.01% 311
2014
Q2 		$528 Buy
8
+3
+60% +$213 ﹤0.01% 268
2014
Q1 		$521 Hold
5
– – ﹤0.01% 268
2013
Q4 		$946 Buy
+5
New +$293 ﹤0.01% 371

Other funds holding PBYI

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Grantham, Mayo, Van Otterloo & Co (GMO)
Grantham, Mayo, Van Otterloo & Co (GMO) Boston, Massachusetts $44.4B AUM 36.05% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Raffa Wealth Management's PBYI Position: Q2 2015 in Review

Raffa Wealth Management sold out of Puma Biotechnology (PBYI) in Q2 2015, closing a stake of 5 shares — an estimated $1.18K sold.

Raffa Wealth Management first reported a position in PBYI in Q4 2013 and held it in 6 quarters. The position peaked at $1.19K in Q3 2014. 198 funds tracked by Wall St. Rank hold PBYI as of Q2 2015.

  • Raffa Wealth Management reported no remaining Puma Biotechnology position as of Q2 2015 after selling out during the quarter.
  • Raffa Wealth Management sold 5 Puma Biotechnology shares in Q2 2015, an estimated $1.18K.
  • Raffa Wealth Management first reported a position in Puma Biotechnology in Q4 2013 and held it in 6 quarters.
  • Raffa Wealth Management's Puma Biotechnology position peaked at $1.19K in Q3 2014.
  • 198 funds tracked by Wall St. Rank held Puma Biotechnology as of Q2 2015.

Based on Raffa Wealth Management's 13F filing for Q2 2015, filed 27 Jul 2026.